Authors: H. Vlčková Authors‘ workplace: OP VZP hl. m. Prahy Published in: Listy rev. Lék., 9, 2005, č. 1, s. 14-16
The paper presents the comparison of expenditure on unregistered pharmaceuticals in the second quarter of the year 2003 and 2004: high expenses on pharmaceuticals used for a long time and so far unregistered, newly introduced pharmaceuticals, increasing proportion of pharmaceuticals in which the registration was not renewed after their validity was finished.
Key words: approval of unregistered pharmaceuticals by the physician reviewer – par. 16 of the law No. 48/1997 – annual increase of cost
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
